Company intelligence / Profile preview
Tianjin Pharmaceutical Holdings
Tianjin, Tianjin, Chinapharm.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The group, via its subsidiaries, markets hundreds of pharmaceutical products (small molecules, biologics, and Chinese medicines) covering commercialized drugs in China and internationally[1][5]. Pipeline or clinical-stage program detail at the group level is not available.
- Therapeutic areas
- Infectious DiseasesGastroenterologyPulmonologyCardiovascularOtherOncologyWomen's Health
- Modalities
- Small moleculeBiologicTraditional Chinese medicineMedical device
- Industry
- Pharma
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Tianjin Pharmaceutical Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tianjin Pharmaceutical Holdings.